SAN DIEGO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc., a clinical‐stage immuno-oncology company at the forefront of cell-based oncolytic virus immunotherapies for cancer, today announced that the CEO of Calidi Biotherapeutics, Allan Camaisa, received the Pillars of Hope Award by the Mitchell Thorp Foundation.…
Calidi BiotherapeuticsDecember 18, 2019